A Witteveen1, I M H Vliegen2, S Siesling3, M J IJzerman4. 1. University of Twente, MIRA Institute for Biomedical Technology & Technical Medicine, Enschede, The Netherlands. 2. University of Twente, Centre for Healthcare Operations Improvement and Research (CHOIR), Enschede, The Netherlands. 3. Comprehensive Cancer Centre the Netherlands (IKNL), Utrecht, The Netherlands. 4. MIRA Institute for Biomedical Technology & Technical Medicine and University of Twente, Enschede, The Netherlands.
Authors: Cornelia D van Steenbeek; Marissa C van Maaren; Sabine Siesling; Annemieke Witteveen; Xander A A M Verbeek; Hendrik Koffijberg Journal: BMC Med Res Methodol Date: 2019-06-08 Impact factor: 4.615